Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Atorvastatin in pulmonary hypertension (apath) study

W-J. Zeng, C-M. Xiong, L. Zhao, G-L. Shan, Z-H. Liu, F. Xue, Q. Gu, X-H. Ni, Z-H. Zhao, X-S. Cheng, M.R. Wilkins, J-G. He on behalf of the Atorvastatin in Pulmonary Arterial Hypertension (APATH) Study Group
European Respiratory Journal 2012; DOI: 10.1183/09031936.00149011
W-J. Zeng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C-M. Xiong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G-L. Shan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z-H. Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Xue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q. Gu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X-H. Ni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z-H. Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X-S. Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.R. Wilkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.wilkins@imperial.ac.uk
J-G. He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hejianguofw@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/09031936.00149011
PubMed 
22362846

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online February 23, 2012.

Article Versions

  • You are currently viewing a previous version of this article (February 23, 2012 - 06:07).
  • View the most recent version of this article
Copyright & Usage 
ERS

Author Information

  1. W-J. Zeng*,§,
  2. C-M. Xiong*,§,
  3. L. Zhao¶§,
  4. G-L. Shan#,
  5. Z-H. Liu*,
  6. F. Xue#,
  7. Q. Gu*,
  8. X-H. Ni*,
  9. Z-H. Zhao*,
  10. X-S. Cheng*,
  11. M.R. Wilkins¶⇓,
  12. J-G. He*⇓ and
  13. on behalf of the Atorvastatin in Pulmonary Arterial Hypertension (APATH) Study Group+
  1. *Pulmonary Vascular Disease Center, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  2. #Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China
  3. ¶Experimental Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 ONN, UK
  4. +Study Group participants are listed in the acknowledgements
  5. §contributed equally as first authors to this manuscript
  1. M.R. Wilkins, Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, E-mail: m.wilkins{at}imperial.ac.uk
  2. J-G. He, Pulmonary Vascular Diseases Center, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Xicheng District, Beijing, 100037, China, E-mail:hejianguofw{at}gmail.com

Article usage

Article usage: February 2012 to August 2023

AbstractFullPdf
Feb 2012116015
Mar 2012180035
Apr 201244013
May 20123508
Jun 20123818
Jul 2012257436177
Aug 2012649949
Sep 20123991435
Oct 2012198717
Nov 2012174716
Dec 2012103511
Jan 2013194412
Feb 2013701117
Mar 201386510
Apr 201373129
May 2013781114
Jun 2013811015
Jul 201342711
Aug 20134747
Sep 201339811
Oct 2013571011
Nov 20134455
Dec 20133014
Jan 2014332828
Feb 20142031119
Mar 2014335419
Apr 2014427426
May 2014222620
Jun 201422149
Jul 2014232014
Aug 2014282815
Sep 2014361912
Oct 2014262618
Nov 2014322824
Dec 2014132331
Jan 2015292414
Feb 2015252231
Mar 2015212426
Apr 2015261824
May 2015141326
Jun 2015233032
Jul 2015211010
Aug 201530916
Sep 20158916
Oct 201521739
Nov 201541218
Dec 201542038
Jan 2016142937
Feb 2016111724
Mar 2016104045
Apr 201661618
May 2016142024
Jun 201643224
Jul 201662126
Aug 201682815
Sep 201642815
Oct 2016104041
Nov 201642322
Dec 201652330
Jan 201736340
Feb 201746218
Mar 2017104221
Apr 201763332
May 201784026
Jun 201762410
Jul 201771917
Aug 20177287
Sep 201772713
Oct 201763413
Nov 20174298
Dec 20172326
Jan 2018102111
Feb 201812211
Mar 201846113
Apr 2018312129
May 201813812
Jun 20185647
Jul 20182426
Aug 20180407
Sep 20180209
Oct 2018123711
Nov 201812488
Dec 201803316
Jan 2019103520
Feb 201933319
Mar 201922511
Apr 201983620
May 201934016
Jun 201924620
Jul 201964628
Aug 201954020
Sep 201908422
Oct 201926918
Nov 201944211
Dec 201913612
Jan 202034622
Feb 202044515
Mar 20205376
Apr 202023110
May 202032916
Jun 202034561
Jul 202033913
Aug 202033313
Sep 2020135738
Oct 202089252
Nov 202063331
Dec 20204638
Jan 202174427
Feb 202126933
Mar 2021115232
Apr 202157124
May 2021710434
Jun 202174919
Jul 202145739
Aug 2021255224
Sep 202184427
Oct 202177955
Nov 202155637
Dec 2021188728
Jan 202294320
Feb 202254516
Mar 2022114448
Apr 202277438
May 202246340
Jun 202285615
Jul 202235920
Aug 202285118
Sep 2022144725
Oct 202265714
Nov 2022114832
Dec 202285013
Jan 202335614
Feb 202365916
Mar 20235499
Apr 202363514
May 202363223
Jun 20236318
Jul 202353528
Aug 202353817

Altmetrics

Next
Back to top
Vol 62 Issue 3 Table of Contents
European Respiratory Journal: 62 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Atorvastatin in pulmonary hypertension (apath) study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Atorvastatin in pulmonary hypertension (apath) study
W-J. Zeng, C-M. Xiong, L. Zhao, G-L. Shan, Z-H. Liu, F. Xue, Q. Gu, X-H. Ni, Z-H. Zhao, X-S. Cheng, M.R. Wilkins, J-G. He
European Respiratory Journal Jan 2012, erj01490-2011; DOI: 10.1183/09031936.00149011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Atorvastatin in pulmonary hypertension (apath) study
W-J. Zeng, C-M. Xiong, L. Zhao, G-L. Shan, Z-H. Liu, F. Xue, Q. Gu, X-H. Ni, Z-H. Zhao, X-S. Cheng, M.R. Wilkins, J-G. He
European Respiratory Journal Jan 2012, erj01490-2011; DOI: 10.1183/09031936.00149011
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Automated quantification of radiological patterns predicts IPF survival
  • Aspergillus fumigatus in COPD
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society